Search research articles
Contact Us
Filters
Showing results (41-50 of 210) with videos related to
Page
of 21
Sort By:
International Journal of Cancer
|
December 10, 2020
DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population
Na Li, Yuanjing Hu, Xinying Zhang, et al.
BMC Infectious Diseases
|
July 5, 2015
Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China
Rong Wang, Xiao-Lei Guo, G Bea A Wisman, et al.
The American Journal of Surgical Pathology
|
July 12, 2005
Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma
Eugenia Haralambieva, Evert-Jan Boerma, Gustaaf W van Imhoff, et al.
British Journal of Cancer
|
February 13, 2008
Cortactin expression predicts poor survival in laryngeal carcinoma
J H Gibcus, M F Mastik, L Menkema, et al.
Genes, Chromosomes & Cancer
|
June 1, 2006
IGH switch breakpoints in Burkitt lymphoma: exclusive involvement of noncanonical class switch recombination
Jeroen E J Guikema, Conny de Boer, Eugenia Haralambieva, et al.
Journal for Immunotherapy of Cancer
|
July 12, 2019
Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors
Menno Tamminga, Sanne de Wit, T Jeroen N Hiltermann, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
Detection of <i>NTRK</i> Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort
Bart Koopman, Chantal C H J Kuijpers, Harry J M Groen, et al.
Plos One
|
November 12, 2014
The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization
Lien Tembuyser, Véronique Tack, Karen Zwaenepoel, et al.
Translational Lung Cancer Research
|
February 4, 2020
Circulating tumor cells in lung cancer are prognostic and predictive for worse tumor response in both targeted- and chemotherapy
Menno Tamminga, Sanne de Wit, Ed Schuuring, et al.
BMC Medical Genomics
|
November 26, 2008
Discovery of DNA methylation markers in cervical cancer using relaxation ranking
Maté Ongenaert, G Bea A Wisman, Haukeline H Volders, et al.
Page
of 21
Search research articles
Search
Showing results (41-50 of 210) with videos related to
Sort By:
Page
of 21
International Journal of Cancer
|
December 10, 2020
DNA methylation markers as triage test for the early identification of cervical lesions in a Chinese population
Na Li, Yuanjing Hu, Xinying Zhang, et al.
BMC Infectious Diseases
|
July 5, 2015
Nationwide prevalence of human papillomavirus infection and viral genotype distribution in 37 cities in China
Rong Wang, Xiao-Lei Guo, G Bea A Wisman, et al.
The American Journal of Surgical Pathology
|
July 12, 2005
Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma
Eugenia Haralambieva, Evert-Jan Boerma, Gustaaf W van Imhoff, et al.
British Journal of Cancer
|
February 13, 2008
Cortactin expression predicts poor survival in laryngeal carcinoma
J H Gibcus, M F Mastik, L Menkema, et al.
Genes, Chromosomes & Cancer
|
June 1, 2006
IGH switch breakpoints in Burkitt lymphoma: exclusive involvement of noncanonical class switch recombination
Jeroen E J Guikema, Conny de Boer, Eugenia Haralambieva, et al.
Journal for Immunotherapy of Cancer
|
July 12, 2019
Circulating tumor cells in advanced non-small cell lung cancer patients are associated with worse tumor response to checkpoint inhibitors
Menno Tamminga, Sanne de Wit, T Jeroen N Hiltermann, et al.
Diagnostics (Basel, Switzerland)
|
March 25, 2022
Detection of <i>NTRK</i> Fusions and TRK Expression and Performance of pan-TRK Immunohistochemistry in Routine Diagnostics: Results from a Nationwide Community-Based Cohort
Bart Koopman, Chantal C H J Kuijpers, Harry J M Groen, et al.
Plos One
|
November 12, 2014
The relevance of external quality assessment for molecular testing for ALK positive non-small cell lung cancer: results from two pilot rounds show room for optimization
Lien Tembuyser, Véronique Tack, Karen Zwaenepoel, et al.
Translational Lung Cancer Research
|
February 4, 2020
Circulating tumor cells in lung cancer are prognostic and predictive for worse tumor response in both targeted- and chemotherapy
Menno Tamminga, Sanne de Wit, Ed Schuuring, et al.
BMC Medical Genomics
|
November 26, 2008
Discovery of DNA methylation markers in cervical cancer using relaxation ranking
Maté Ongenaert, G Bea A Wisman, Haukeline H Volders, et al.
Page
of 21